Okada, N., Niimura, T., Zamami, Y., Hamano, H., Ishida, S., Goda, M., . . . Ishizawa, K. (2018). Pharmacovigilance evaluation of the relationship between impaired glucose metabolism and BCR‐ABL inhibitor use by using an adverse drug event reporting database. Cancer Med.
Citação norma ChicagoOkada, Naoto, et al. "Pharmacovigilance Evaluation of the Relationship between Impaired Glucose Metabolism and BCR‐ABL Inhibitor Use By Using an Adverse Drug Event Reporting Database." Cancer Med 2018.
MLA引文Okada, Naoto, et al. "Pharmacovigilance Evaluation of the Relationship between Impaired Glucose Metabolism and BCR‐ABL Inhibitor Use By Using an Adverse Drug Event Reporting Database." Cancer Med 2018.
警告：這些引文格式不一定是100％准確.